-
Something wrong with this record ?
Fast Facts: Bladder Cancer
Seth P. Lerner, Ian D. Davis
- Published
- Basel : S. Karger, 2018
- Edition
- 3rd edition
- Pagination
- 96 stran : ilustrace
Language English Country Germany
Document type Handbook
Knihovny.cz ISBN
9781910797655
plný text - pouze pro uživatele NLK
Karger Fast Facts e-book
Knihovny.cz E-resources
Our understanding of the biology of bladder cancer has advanced remarkably since the second edition of 'Fast Facts: Bladder Cancer' was published in 2006. Five new immunotherapies targeting the PD-1 axis were approved in 2016 and 2017 for the treatment of advanced bladder cancer, reflecting this transformative explosion in knowledge about the biology of the disease.This new era of targeted treatment offers hope to patients, particularly those with advanced disease. However, for clinicians it means a lot to understand in terms of how these immunotherapies are integrated into the treatment paradigm. Who they are suitable for? When are they best used? What is the optimal sequence of treatments for individual patients?This third edition of 'Fast Facts: Bladder Cancer' has been updated extensively throughout by two new authors, bringing a fresh perspective. Key updates include:• the latest understanding of pathology and biology• current standards for investigation, imaging and diagnosis• the critical role that awareness of the significance of hematuria among patients and primary care health professionals can make to earlier detection at curable stages of the disease• the roles of drugs, surgery and radiation therapy in treatment at different stages of bladder cancer, and when and how best to intervene, aided by understanding of the risk factors for disease relapse and progression• a new chapter about immunotherapy for bladder cancer• future trends in a rapidly evolving field.'Fast Facts: Bladder Cancer' is a concise guide that will be of value to clinicians and health professionals involved in the detection and treatment of bladder cancer. This highly readable resource provides a comprehensive and current view of this complex disease, enabling informed discussions with patients.Contents:• Epidemiology and etiology• Pathology and biology• Clinical presentation• Investigations• Management of non-muscle-invasive disease• Management of muscle-invasive disease• Management of advanced and metastatic disease• Immunotherapy• Future trends• Useful resources
Bladder Cancer
Print version record
| Owner | Details | Services |
|---|---|---|
| NLK | NLK Shelf no. ebook [0] | see E-resources |
- 000
- 02884nam a22002655u 4500
- 001
- krg277616
- 003
- CZ-PrNML
- 005
- 20210222091020.0
- 006
- m o d
- 007
- cr unu
- 008
- 210217s2018 gw a o 001 0 eng d
- 009
- eBK
- 020 __
- $a 9781910797655
- 035 __
- $a (OCoLC)1028848893
- 040 __
- $a UKSKG $b cze $c UKSKG $b ABA008 $d ABA008
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Lerner, Seth P.
- 245 10
- $a Fast Facts: Bladder Cancer / $c Seth P. Lerner, Ian D. Davis
- 246 00
- $a Bladder Cancer
- 250 __
- $a 3rd edition
- 260 __
- $a Basel : $b S. Karger, $c 2018
- 300 __
- $a 96 stran : $b ilustrace
- 520 __
- $a Our understanding of the biology of bladder cancer has advanced remarkably since the second edition of 'Fast Facts: Bladder Cancer' was published in 2006. Five new immunotherapies targeting the PD-1 axis were approved in 2016 and 2017 for the treatment of advanced bladder cancer, reflecting this transformative explosion in knowledge about the biology of the disease.This new era of targeted treatment offers hope to patients, particularly those with advanced disease. However, for clinicians it means a lot to understand in terms of how these immunotherapies are integrated into the treatment paradigm. Who they are suitable for? When are they best used? What is the optimal sequence of treatments for individual patients?This third edition of 'Fast Facts: Bladder Cancer' has been updated extensively throughout by two new authors, bringing a fresh perspective. Key updates include:• the latest understanding of pathology and biology• current standards for investigation, imaging and diagnosis• the critical role that awareness of the significance of hematuria among patients and primary care health professionals can make to earlier detection at curable stages of the disease• the roles of drugs, surgery and radiation therapy in treatment at different stages of bladder cancer, and when and how best to intervene, aided by understanding of the risk factors for disease relapse and progression• a new chapter about immunotherapy for bladder cancer• future trends in a rapidly evolving field.'Fast Facts: Bladder Cancer' is a concise guide that will be of value to clinicians and health professionals involved in the detection and treatment of bladder cancer. This highly readable resource provides a comprehensive and current view of this complex disease, enabling informed discussions with patients.Contents:• Epidemiology and etiology• Pathology and biology• Clinical presentation• Investigations• Management of non-muscle-invasive disease• Management of muscle-invasive disease• Management of advanced and metastatic disease• Immunotherapy• Future trends• Useful resources
- 588 0_
- $a Print version record
- 650 07
- $a urologie $2 czmesh $7 D014572
- 650 07
- $a nádory močového měchýře $7 D001749 $2 czmesh
- 650 07
- $a urologie $7 nlk20040148342 $2 mednas
- 650 07
- $a onkologie $7 nlk20040148136 $2 mednas
- 655 _7
- $a příručky $7 D020479 $2 czmesh
- 700 1_
- $a Davis, Ian D.
- 776 08
- $i Print version: $t Fast Facts: Bladder Cancer $z 9781910797648
- 856 40
- $u https://www.medvik.cz/link/access.do?source=portal&url=https://www.karger.com/Book/Home/277616 $y plný text - pouze pro uživatele NLK $z Karger Fast Facts e-book
- 910 __
- $a ABA008 $b ebook $t l $y x
- 990 __
- $a 20210218 $b ABA008
- 991 __
- $a 20210222090636 $b ABA008
- 999 __
- $a ok $b medvik21 $g 1622925 $s 222028